Cardinal Health, Inc. (CAH) operates as a healthcare services and products company with a large global footprint. The company's wide range of offerings, from pharmaceuticals to medical products, makes it a versatile player in the healthcare sector. This analysis delves into its fundamental ratings and future outlook based on both historical and analyst-driven insights.
Cardinal Health's fundamental ratings provide insights into its financial health and operational efficiency. These scores reflect various financial metrics that investors consider crucial for assessing company performance.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow (DCF) | 5 | |
| Return on Equity (ROE) | 1 | |
| Return on Assets (ROA) | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 1 | |
| Price to Book (P/B) | 1 |
The historical ratings illustrate how Cardinal Health's assessment has evolved over time, providing context for its current standing.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-20 | 2 | 5 | 1 | 4 | 1 | 1 | 1 |
| 2025-08-19 | 0 | 5 | 1 | 4 | 1 | 1 | 1 |
Analyst projections provide a range of expected stock price outcomes for Cardinal Health, assisting investors in decision-making.
| High | Low | Median | Consensus |
|---|---|---|---|
| 186 | 150 | 180 | 174 |
The distribution of analyst recommendations shows a predominantly positive outlook for Cardinal Health's stock.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 15 | |
| Sell | 0 | |
| Strong Sell | 0 |
Cardinal Health shows a mixed fundamental profile with strong DCF valuation but weak ROE and ROI. Analyst forecasts are optimistic with a median price target higher than the current trading range. The sentiment is largely supportive of a "Buy" but balanced by a significant "Hold" proportion. Despite certain financial inefficiencies, the company's diversified healthcare services might drive continued growth, provided they address leverage and revenue consistency.